Dabur India: A healthy show

Dabur India: A healthy show

Shares of Dabur India gained more than 2% to trade at Rs 527.25 apiece Wednesday as the ‘Chyawanprash’ maker reported 20% rise in net profit to Rs 392.70 crore during the fiscal second quarter to September 30.
The home-grown consumer goods maker, on Tuesday, reported a 13.7% growth in consolidated revenue at Rs 2,516 crore, the highest revenue growth in the last couple of years.
It’s e-commerce business grew by over 200% in the quarter and now contributes 6% to its overall sales compared to 2.1% a year earlier.
This stupendous growth in revenue is attributed to focus on its core healthcare portfolio, investments behind power brands and distribution expansion.
Dabur’s India FMCG business reported a revenue increase of 19.8% in the quarter.
Dabur reported a 49% growth in its healthcare business, led by immunity-boosting products such as Chyawanprash. Its home and personal care business grew by high single digits, while the domestic foods business grew on riding on an in-home surge in consumption.
Health supplements business grew 70.8% growth in the quarter.
Rural demand grew ahead of urban; favourable monsoon and enhanced stimulus announced by the government is expected to further drive rural demand in the coming months.

Disclaimer –
This document is meant for the recipient only for use as intended and not for circulation. This document should not be reproduced or copied or made available to others. The information contained herein is from the public domain or sources believed to be reliable. While reasonable care has been taken to ensure that information given is at the time believed to be fair and correct and opinions based thereupon are reasonable, due to the very nature of research it cannot be warranted or represented that it is accurate or complete and it should not be relied upon as such. Also above note is not a recommendation to Buy or SELL and is only a view based on facts and figures and we will be in no way responsible for any losses incurred by anyone who uses this information to either trade or invests securities mentioned herein.